Biomarin Announces Legal Action Against Ascendis Pharma A/S In European Unified Patent Court
(MENAFN- PR Newswire) SAN RAFAEL, Calif., Jan. 13, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that the company has initiated a legal action against Ascendis Pharma A/S for infringement of European patent …